COVID2019 and stock investing – Part 4 – is it a blessing in disguise for the Indian economy !
At first read, the presented arguments may sound counter intuitive. However, think carefully and you might agree.
Sector: Pharma
First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health’s Guardant360® CDx, gains credibility among oncologists in Asia, Middle East…
The U.S. Food and Drug Administration (FDA) has approved Guardant Health’s liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval represents a landmark achievement of the Guardant360 test. Currently, the liquid biopsy is commercially available in 41 countries in … Read more
Advent International to acquire controlling stake in RA Chem Pharma
Though Advent did not provide any financial details or the percentage of the stake to be acquired, sources in know of the matter said the deal gives RA Chem Pharma an enterprise value of around Rs 1,000 crore. They also said the PE firm is acquiring up to 60 per cent stake in the pharmaceutical … Read more
India seeks new preferential treatment from US on drugs, other goods
In return for opening its dairy markets and slashing tariffs on farm goods as the two sides seek to shore up a new trade deal, three sources said. India accounts for 40% of US generic drug imports, including the anti-malarial hydroxychloroquine, touted by US President Donald Trump in the fight against the coronavirus. To win … Read more
Eli Lilly Covid-19 treatment could be authorised by September: Chief Scientist
If all goes well with either of two antibody therapies it is testing. Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the new coronavirus that could enter human clinical trials in the coming weeks, Chief Scientific Officer Daniel Skovronsky said in an interview. Lilly has already launched … Read more
AstraZeneca eyes record pharma merger with Gilead
The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up, the people said, asking not to be identified because the details are private. AstraZeneca didn’t specify terms for any transaction, they said. While Gilead has discussed the idea with advisers, no decisions have been made on how to proceed … Read more
Government lifts curbs on exports of paracetamol APIs
Export curbs were imposed on paracetamol and formulations made from the compound on March 3 by the government to shore up domestic supplies amid the threat of the coronavirus pandemic. On April 17, the government removed the curbs on shipments of formulations made from paracetamol. Now, the Directorate General of Foreign Trade (DGFT) has removed … Read more
USFDA accepts Biocon-Mylan drug application for colon cancer
In a positive for Biocon, US drug regulator USFDA has accepted a biologics licence application by biopharmaceutical major and partner Mylan for a proposed biosimilar to treat advanced colon or rectal cancer. The application seeks approval of biosimilar bevacizumab for treatment of patients with metastatic colorectal cancer in addition to other ailments. “Once approved, our … Read more
Wockhardt gets nod for antibiotics aimed at AMR
In a first, pharma major Wockhardt has got the nod from the Drug Controller General of India (DCGI) for two new antibiotic medicines, which it plans to launch in the Indian market over the next few months. In the last 15 years, there has been no new antibiotic launch in this category (gram-positive bacterial infections) … Read more